Nonclinical services for the development of interventional agents for infectious diseases
Ended Awarded Last action
- Contract number
- 75N93024F00003
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,281,252
Award facts
- Contract value 43% obligated
-
- $2,281,252.00 Current, with exercised options
- $5,310,519.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $762,892 | |
| Other Administrative Action | $510,786 | |
| Modification | $1,007,574 | |
| Exercise an Option | $0 |
About this award
This is a $5,310,519.00 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to SRI International, a non-profit research institute, for nonclinical services to support the development of interventional agents for infectious diseases. The contract was issued under the "Nonclinical Services for Development of Interventional Agents" master IDIQ contract. The contract does not have a small business set-aside designation. SRI International has subcontracted portions of the work to Charles River Laboratories, a global CRO that provides specialized research products and services to government agencies, including laboratory animals, diagnostic testing, and other critical materials for biomedical research. This contract supports NIAID's mission to conduct and support research to study, treat, and prevent infectious diseases.
Quick answers
Who was awarded contract 75N93024F00003?
75N93024F00003 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 16, 2024.
How much is contract 75N93024F00003 worth?
The government has obligated $2,281,252 on 75N93024F00003. Its potential value, with all options, is $5,310,519.
Is contract 75N93024F00003 an order under another contract?
Yes. 75N93024F00003 is a delivery order under 75N93018D00001, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93024F00003 competed?
The extent of competition for 75N93024F00003 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award